Codiak BioSciences, Inc.
CDAKDelisted May 2, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001659352
Codiak BioSciences, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Mar 30, 2023; 27 institutions reported holding it in 13F filings for Q1 2023, worth $1.44M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Codiak BioSciences, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 27 | 1 | −26 |
| Shares | 8.24M | 23.9K | −8.22M (−99.7%) |
| Value | $1.44M | $0 | −$1.44M (−100.0%) |
New holders (0)
Institutions that held Codiak BioSciences, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
None.
Sold out (26)
Institutions that held Codiak BioSciences, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Flagship Pioneering Inc. | 3,540,636 | $617.8K |
| Laurion Capital Management LP | 2,013,300 | $351.3K |
| University of Texas/Texas Am Investment Managment Co | 847,108 | $148.0K |
| Vanguard Group Inc | 580,770 | $101.3K |
| FMR LLC | 448,539 | $78.3K |
| Ensign Peak Advisors, Inc | 252,782 | $44.1K |
| Millennium Management LLC | 161,957 | $28.0K |
| Forefront Analytics, LLC | 110,210 | $19.2K |
| Parametrica Management Ltd | 65,098 | $11.0K |
| Bank of America Corp | 53,055 | $9.23K |
| HRT Financial LP | 30,566 | $5.00K |
| HighTower Advisors, LLC | 20,328 | $4.00K |
| Geode Capital Management, LLC | 21,826 | $3.81K |
| Pathstone Family Office, LLC | 17,000 | $2.97K |
| Morgan Stanley | 15,334 | $2.67K |
| Citadel Advisors LLC | 12,740 | $2.22K |
| Virtu Financial LLC | 10,491 | $2.00K |
| National Asset Management, Inc. | 10,000 | $1.75K |
| Tower Research Capital LLC (TRC) | 7,165 | $1.00K |
| Advisor Group Holdings, Inc. | 667 | $116 |
| Wells Fargo & Company | 332 | $58 |
| US Bancorp | 300 | $52 |
| Investors Research Corp | 100 | $17 |
| UBS Group AG | 91 | $16 |
| Salem Investment Counselors Inc | 50 | $9 |
| JPMorgan Chase & Co | 79 | $0 |